Brooktree Capital Management boosted its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.4% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 33,550 shares of the company’s stock after buying an additional 138 shares during the quarter. Johnson & Johnson makes […]
Brooktree Capital Management increased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.4% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 33,550 shares of the company’s stock after acquiring an additional 138 shares during the period. Johnson & Johnson makes up about 4.0% of […]
Brooktree Capital Management reduced its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 44.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,753 shares of the company’s stock after selling 3,742 shares during the period. AbbVie accounts for about […]
Brooktree Capital Management lifted its position in Rocket Companies, Inc. (NYSE:RKT – Free Report) by 46.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 132,625 shares of the company’s stock after acquiring an additional 41,770 shares during the period. Rocket Companies […]
Brooktree Capital Management purchased a new stake in shares of Stryker Co. (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 800 shares of the medical technology company’s stock, valued at approximately $228,000. Other institutional investors have also recently added to or reduced their […]